Literature DB >> 15293074

Influenza-associated myositis in children.

P Agyeman1, A Duppenthaler, U Heininger, C Aebi.   

Abstract

BACKGROUND: Influenza-associated myositis (IAM) is an infrequent and poorly known complication of influenza virus infection in children. The aim of this study was to describe five cases of IAM and to review the literature on IAM in children. PATIENTS AND METHODS: We conducted a retrospective analysis of cases of IAM diagnosed at two university children's hospitals in Switzerland during two consecutive influenza seasons. Findings were compared with 39 individual case reports and five publications summarizing an additional 272 cases identified by a medical online library (MEDLINE) search.
RESULTS: Overall, 316 cases were analyzed. IAM typically occurred in school-aged children with a 2:1 male predominance. Influenza B and A viruses were identified in 76% and 24% of cases, respectively. The median interval between onset of influenza and onset of IAM was 3 days (range 0-18). The calf muscles were involved alone or together with other muscle groups in 69% and 31% of cases, respectively. Blood creatine phosphokinase (CPK) concentration was invariably elevated. Median duration to clinical recovery was 3 days (range 1-30). Rhabdomyolysis occurred in ten of 316 patients (3%), was more common in girls (80%), more often associated with influenza A (86%), and led to renal failure in eight patients (80%).
CONCLUSION: Clinical and laboratory findings of IAM are highly characteristic and allow a rapid diagnosis during the influenza season.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15293074     DOI: 10.1007/s15010-004-4003-2

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  39 in total

1.  Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the Department of Health.

Authors: 
Journal:  Thorax       Date:  2007-01       Impact factor: 9.139

2.  A stiff-legged gait: benign acute childhood myositis.

Authors:  Sangeeta Jain; Michael R Kolber
Journal:  CMAJ       Date:  2009-10-13       Impact factor: 8.262

3.  Benign acute myositis in an adult patient.

Authors:  Jean-Baptiste Chanson; Claude Dakayi; Béatrice Lannes; Andoni Echaniz-Laguna
Journal:  BMJ Case Rep       Date:  2018-05-29

4.  Viral myositis in children.

Authors:  Haley Magee; Ran D Goldman
Journal:  Can Fam Physician       Date:  2017-05       Impact factor: 3.275

5.  Benign acute myositis associated with H1N1 influenza A virus infection.

Authors:  Esther Rubín; Luis De la Rubia; Andrea Pascual; Jana Domínguez; Cristina Flores
Journal:  Eur J Pediatr       Date:  2010-03-07       Impact factor: 3.183

6.  Splenic priming of virus-specific CD8 T cells following influenza virus infection.

Authors:  Damian L Turner; Kara L Bickham; Donna L Farber; Leo Lefrançois
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

Review 7.  Pathology of human influenza revisited.

Authors:  Thijs Kuiken; Jeffery K Taubenberger
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

8.  Two-dimensional gel electrophoresis analysis in simultaneous influenza pneumonia and bacterial infection in mice.

Authors:  K Kosai; M Seki; K Yanagihara; S Nakamura; S Kurihara; Y Imamura; K Izumikawa; H Kakeya; Y Yamamoto; T Tashiro; S Kohno
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

Review 9.  Bacterial, fungal, parasitic, and viral myositis.

Authors:  Nancy F Crum-Cianflone
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

10.  Severe pneumonia associated with pandemic (H1N1) 2009 outbreak, San Luis Potosí, Mexico.

Authors:  Alejandro Gómez-Gómez; Martin Magaña-Aquino; Christian Garcia-Sepúlveda; Uciel R Ochoa-Pérez; Reynaldo Falcón-Escobedo; Andreu Comas-García; Saray Aranda-Romo; Hugo I Contreras-Treviño; Paulina V Jimenéz-Rico; Mario A Banda-Barbosa; Félix Dominguez-Paulin; J Mario Bernal-Blanco; Luis F Peréz-González; Daniel E Noyola
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.